{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:21:19Z","timestamp":1793996479769,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["US20200353048A1"],"award-info":[{"award-number":["US20200353048A1"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["US10695406B2"],"award-info":[{"award-number":["US10695406B2"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["US63\/384149"],"award-info":[{"award-number":["US63\/384149"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020481","name":"Australian and New Zealand Society for Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001202","name":"Gastroenterological Society of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015471","name":"Mater Foundation","doi-asserted-by":"publisher","award":["AU2015268101B2"],"award-info":[{"award-number":["AU2015268101B2"]}],"id":[{"id":"10.13039\/100015471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.molmed.2024.10.016","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:57:24Z","timestamp":1732208244000},"page":"574-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Harnessing IL-22 for metabolic health: promise and pitfalls"],"prefix":"10.1016","volume":"31","author":[{"given":"Haressh","family":"Sajiir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme A.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"McGuckin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes B.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-8628","authenticated-orcid":false,"given":"Sumaira Z.","family":"Hasnain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.10.016_bb0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","article-title":"Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9","volume":"164","author":"Dumoutier","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0010","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.gene.6363716","article-title":"IL-TIF\/IL-22: genomic organization and mapping of the human and mouse genes","volume":"1","author":"Dumoutier","year":"2000","journal-title":"Genes Immun."},{"key":"10.1016\/j.molmed.2024.10.016_bb0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2024.10.016_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1144","article-title":"The role of interleukin-22 in mammalian intestinal homeostasis: friend and foe","volume":"12","author":"Klotskova","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.molmed.2024.10.016_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13564","article-title":"Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes","volume":"514","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.10.016_bb0030","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/nm.3705","article-title":"Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress","volume":"20","author":"Hasnain","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.10.016_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22\u2013IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2024.10.016_bb0040","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.str.2008.06.005","article-title":"Structure of IL-22 bound to its high-affinity IL-22R1 chain","volume":"16","author":"Jones","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2024.10.016_bb0045","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.febslet.2008.07.046","article-title":"Crystal structure of the IL-22\/IL-22R1 complex and its implications for the IL-22 signaling mechanism","volume":"582","author":"Bleicher","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2024.10.016_bb0050","doi-asserted-by":"crossref","first-page":"33676","DOI":"10.1074\/jbc.M204204200","article-title":"Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line: pathways that are shared with and distinct from IL-10","volume":"277","author":"Lejeune","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.10.016_bb0055","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201376","article-title":"Islet Gene View \u2013 a tool to facilitate islet research","volume":"5","author":"Asplund","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.molmed.2024.10.016_bb0060","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1038\/s41467-024-48320-2","article-title":"Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis","volume":"15","author":"Sajiir","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.10.016_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13578-015-0015-0","article-title":"Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences","volume":"5","author":"Park","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.molmed.2024.10.016_bb0070","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-15-0232","article-title":"Oxidative and endoplasmic reticulum stress in \u03b2-cell dysfunction in diabetes","volume":"56","author":"Hasnain","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2045-9769-2-2","article-title":"The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes","volume":"2","author":"Hill","year":"2013","journal-title":"Cell Regen."},{"key":"10.1016\/j.molmed.2024.10.016_bb0080","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jcmgh.2022.08.001","article-title":"Sex-dependent hepatoprotective role of IL-22 receptor signaling in non-alcoholic fatty liver disease-related fibrosis","volume":"14","author":"Abdelnabi","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7150\/ijbs.3967","article-title":"Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway","volume":"8","author":"Feng","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.molmed.2024.10.016_bb0090","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2012.08.051","article-title":"Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis","volume":"143","author":"Xue","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2024.10.016_bb0095","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2019.12.010","article-title":"Interleukin 22 signaling regulates acinar cell plasticity to promote pancreatic tumor development in mice","volume":"158","author":"Perusina Lanfranca","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2024.10.016_bb0100","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","article-title":"IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn\u2019s disease","volume":"178","author":"Wolk","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archsurg.1993.01420130026005","article-title":"Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response","volume":"128","author":"Geller","year":"1993","journal-title":"Arch. Surg."},{"key":"10.1016\/j.molmed.2024.10.016_bb0110","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","article-title":"In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression","volume":"54","author":"Park","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2024.10.016_bb0115","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.24486","article-title":"Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3","volume":"54","author":"Jiang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2024.10.016_bb0120","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2024.10.016_bb0125","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.7150\/ijbs.38925","article-title":"Interleukin 22 in liver injury, inflammation and cancer","volume":"16","author":"Wu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.molmed.2024.10.016_bb0130","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.cmet.2024.08.012","article-title":"IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.10.016_bb0135","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.7150\/thno.43894","article-title":"Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.molmed.2024.10.016_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","article-title":"Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22","volume":"53","author":"Yang","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.molmed.2024.10.016_bb0150","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1038\/s41467-024-48317-x","article-title":"Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis","volume":"15","author":"Sajiir","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.10.016_bb0155","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41467-024-45568-6","article-title":"Intestinal IL-22RA1 signaling regulates intrinsic and systemic lipid and glucose metabolism to alleviate obesity-associated disorders","volume":"15","author":"Gaudino","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.10.016_bb0160","article-title":"Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver","author":"Huang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2024.10.016_bb0165","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0170","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-\u03b3 are not","volume":"87","author":"Wolk","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.molmed.2024.10.016_bb0180","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3389\/fimmu.2020.02148","article-title":"A double edged sword role of interleukin-22 in wound healing and tissue regeneration","volume":"11","author":"Arshad","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/apm.13221","article-title":"Role of IL-22 in homeostasis and diseases of the skin","volume":"130","author":"Lopez","year":"2022","journal-title":"APMIS"},{"key":"10.1016\/j.molmed.2024.10.016_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2018.06.008","article-title":"IL22 inhibits epithelial stem cell expansion in an ileal organoid model","volume":"7","author":"Zwarycz","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0195","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230106","article-title":"Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells","volume":"220","author":"Moniruzzaman","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2024.10.016_bb0200","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.10.016_bb0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.10.016_bb0210","doi-asserted-by":"crossref","first-page":"956","DOI":"10.4049\/jimmunol.1801308","article-title":"IL-22 preserves gut epithelial integrity and promotes disease remission during chronic Salmonella infection","volume":"202","author":"Lo","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0215","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41385-020-00348-5","article-title":"IL-22 receptor signaling in Paneth cells is critical for their maturation, microbiota colonization, Th17-related immune responses, and anti-Salmonella immunity","volume":"14","author":"Gaudino","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119195","article-title":"Mechanisms and regulation of IL-22-mediated intestinal epithelial homeostasis and repair","volume":"271","author":"Patnaude","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.molmed.2024.10.016_bb0225","doi-asserted-by":"crossref","first-page":"28990","DOI":"10.1038\/srep28990","article-title":"High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22","volume":"6","author":"Gulhane","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2024.10.016_bb0230","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.3390\/ijms20143468","article-title":"Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1\/2 pathway","volume":"20","author":"Moniruzzaman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.10.016_bb0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2017.05.009","article-title":"IL-22 upregulates epithelial claudin-2 to drive diarrhea and enteric pathogen clearance","volume":"21","author":"Tsai","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.molmed.2024.10.016_bb0240","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1002\/jcb.27194","article-title":"Downregulation of IL-22 can be considered as a risk factor for onset of type 2 diabetes","volume":"119","author":"Asadikaram","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2024.10.016_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8254797","article-title":"Interleukin-22 might act as a double-edged sword in type 2 diabetes and coronary artery disease","volume":"2016","author":"Gong","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.molmed.2024.10.016_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111776","article-title":"Down-regulating interleukin-22\/interleukin-22 binding protein axis promotes inflammation and aggravates diet-induced metabolic disorders","volume":"557","author":"Gu","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0255","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.10.016_bb0260","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2023.2253347","article-title":"Interleukin-22 promotes proliferation and reverses LPS-induced apoptosis and steroidogenesis attenuation in human ovarian granulosa cells: implications for polycystic ovary syndrome pathogenesis","volume":"36","author":"Liu","year":"2023","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.molmed.2024.10.016_bb0265","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gaae037","article-title":"Interleukin-22 improves ovulation in polycystic ovary syndrome via STAT3 signaling","author":"Liao","year":"2024","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.molmed.2024.10.016_bb0270","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1021\/acsami.8b19717","article-title":"Targeted interleukin-22 gene delivery in the liver by polymetformin and penetratin-based hybrid nanoparticles to treat nonalcoholic fatty liver disease","volume":"11","author":"Zai","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.molmed.2024.10.016_bb0275","doi-asserted-by":"crossref","DOI":"10.2337\/db24-48-OR","article-title":"Novel lipidated interleukin-22 reduces body weight and improves glucose homeostasis in mice","volume":"73","author":"van de Bunt","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2024.10.016_bb0280","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2024.10.016_bb0285","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41423-018-0029-8","article-title":"Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects","volume":"16","author":"Tang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.molmed.2024.10.016_bb0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cpt.1164","article-title":"Randomized Phase I healthy volunteer study of UTTR1147A (IL-22Fc): a potential therapy for epithelial injury","volume":"105","author":"Rothenberg","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2024.10.016_bb0295","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2021.03.008","article-title":"The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design","volume":"54","author":"Saxton","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2024.10.016_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202401499","article-title":"Delivery of synthetic interleukin-22 mRNA to hepatocytes via lipid nanoparticles alleviates liver injury","author":"Ouyang","year":"2024","journal-title":"Small"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:28:23Z","timestamp":1792124903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424002831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1471491424002831"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.10.016","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing IL-22 for metabolic health: promise and pitfalls","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}